http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-299041-A5

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3be2429bd1a83fd492acffa31808839c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-175
filingDate 1989-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03ff033c13f5310bd52898688ef30ab1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea6f93702dffd6ff0f7b7f153e4bcc54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22479bc95a3d5fbd851b7dc8c89f946f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e33e1b76037f9e5b592cda2de5188dfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3cedb5075fb0d5a1bb4df6b16b32e88
publicationDate 1992-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-299041-A5
titleOfInvention METHOD FOR THE PRODUCTION OF A MEDIUM AGAINST RETROVIRAL DISEASES
abstract The invention relates to a method for producing an agent against retroviral diseases, which ensures a high bioavailability. Field of application is the pharmaceutical industry. According to the invention, ambazon is processed in the form of soluble salts with pharmaceutical excipients and adjuvants and is prepared therefrom into injection and infusion solutions, tablets, capsules, dragees and zebrafish. retroviral diseases; HIV; bioavailability; Toxicity; Injection; Infusion; Solubilising agents; tablets; capsules; Dragee; suppositories; ambazone}
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0963197-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0963197-A4
priorityDate 1989-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21328
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ4KTA7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9NBX4
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP71276
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ95SX7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6A548
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ94819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549158
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO13339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19593
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1PS67
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08548
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID7955
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21329
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ46666
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ94818
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO77448
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV59
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID7955
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8LKW0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO76332
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO00939
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23070
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO70372
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06163
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV94
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9SPU7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27ID4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV86
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV89
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO14746
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ47526
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529771
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ673L6

Total number of triples: 56.